News Image

Which stocks are moving on Wednesday?

By Mill Chart

Last update: Apr 3, 2024

Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Today's top gainers

TickerChangeComment
UCAR10.0K%U POWER LTD's (NASDAQ:UCAR) shares rose 10.0K% to $6.1 during Wednesday's session. In the last 3 months the share price dropped with 57.12%.
RENT2.0K%RENT THE RUNWAY INC-A's (NASDAQ:RENT) stock price is advancing with 2.0K% to a price of $6.44. The stock is trading 29.98% lower than 3 months ago.
KTRA77.69%Positive market sentiment drove KINTARA THERAPEUTICS INC's (NASDAQ:KTRA) stock price up by 77.69% to $0.18 during Wednesday's session. A press release (KTRA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Kintara Therapeutics, Inc. Is Fair to Shareholders) was released earlier today.
EGOX51.15%Investors celebrated as NEXT.E.GO NV (NASDAQ:EGOX) experienced a 51.15% rise in its shares, closing at $0.04 during Wednesday's session. The stock is trading 79.53% lower than a month ago.
VNDA40.24%With a 40.24% surge, VANDA PHARMACEUTICALS INC's (NASDAQ:VNDA) stock price reached $5.48 during Wednesday's session, signaling positive momentum. The stock is trading 43.09% lower than a year ago.
SBFM32.72%SUNSHINE BIOPHARMA INC (NASDAQ:SBFM) rose 32.72% to $0.11 during Wednesday's after hours session. In the last month the stock gained 82.41%.
SWVL31.49%SWVL HOLDINGS CORP (NASDAQ:SWVL) witnessed a notable 31.49% uptick in its shares, reaching $20.0 during Wednesday's session. The stock is trading 182.0% higher than a month ago.
ORGN31.35%ORIGIN MATERIALS INC (NASDAQ:ORGN) experienced a significant 31.35% increase, reaching $0.64 during Wednesday's session. Earlier today the company had a press release: Origin Materials Converts Wood Residue Feedstock into Sustainable Intermediates at Commercial-Scale Plant.
COCH29.2%ENVOY MEDICAL INC (NASDAQ:COCH) experienced a significant 29.2% increase, reaching $5.79 during Wednesday's session. A press release (Envoy Medical to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024) was released earlier today.
ACB28.5%AURORA CANNABIS INC (NASDAQ:ACB) rose 28.5% to $6.44 during Wednesday's after hours session. In the last month the share price increased with 65.18%.

Our top gainers page will show you the full list.

Top losers

TickerChangeComment
CASA-80.58%CASA SYSTEMS INC's (NASDAQ:CASA) stock price is declining with 80.58% to a price of $0.05. Earlier today the company had a press release: Casa Systems Initiates Court-Supervised Chapter 11 Sale Process for Businesses.
VIEW-62.73%VIEW INC's (NASDAQ:VIEW) stock price decreased by 62.73% to $0.41. A press release (View, Inc. Reaches Agreement with Cantor Fitzgerald and RXR to Become a Private Company) was released yesterday.
SINT-44.01%SINTX TECHNOLOGIES INC's (NASDAQ:SINT) shares fell 44.01% to $0.02 during Wednesday's session. In the last month the share price dropped with 69.84%.
TCON-39.08%TRACON PHARMACEUTICALS INC's (NASDAQ:TCON) stock price faced a 39.08% decline, reaching $0.25 during Wednesday's session. A press release (TRACON Pharmaceuticals Provides Update on Ongoing ENVASARC Phase 2 Pivotal Trial Following Independent Data Monitoring Committee Recommendation to Continue the Trial as Planned) was released earlier today.
MTNB-37.14%MATINAS BIOPHARMA HOLDINGS I's (NYSEARCA:MTNB) shares fell 37.14% to $0.22. In the last month the stock gained 30.06%.
FGEN-34.97%There was a notable decline in FIBROGEN INC's (NASDAQ:FGEN) shares, as they dropped 34.97% to $1.4 during Wednesday's session. In the last 3 months the share price increased with 188.0%.
JZXN-34.65%JIUZI HOLDINGS INC's (NASDAQ:JZXN) stock price faced a 34.65% decline, reaching $2.45 during Wednesday's session. In the last month the stock gained 205.0%.
ANGH-26.66%There was a notable decline in ANGHAMI INC's (NASDAQ:ANGH) shares, as they dropped 26.66% to $1.32 during Wednesday's session. In the last month the share price increased with 93.03%.
BCAN-24.21%The market experienced a downward movement in BYND CANNASOFT ENTERPRISES's (NASDAQ:BCAN) stock price, closing at $0.95 with a 24.21% decrease during Wednesday's session. A press release (Israeli Technology Company BYND Cannasoft Enterprises Inc. Announces Financial Results For The Year Ended December 31, 2023) was released yesterday.
VLCN-23.12%VOLCON INC's (NASDAQ:VLCN) stock price is declining with 23.12% to a price of $0.34. The stock is trading 58.71% lower than a month ago.

Our top losers page will show you the full list.

Back

FIBROGEN INC

NASDAQ:FGEN (5/2/2024, 1:33:04 PM)

1.2

+0.03 (+2.56%)

FGEN News

News Image3 days ago - FibroGen, Inc.FibroGen to Report First Quarter 2024 Financial Results

SAN FRANCISCO, April 29, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce first quarter 2024 financial results on Monday, May 6 after...

News Image8 days ago - FibroGen, Inc.FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer will be Presented at the 2024 American Society of Clinical Oncology

SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that clinical data from the dose escalation portion of...

News Imagea month ago - Market News VideoNotable Wednesday Option Activity: FGEN, PLCE, MDB
News Imagea month ago - Market News VideoCommit To Buy FibroGen At $1, Earn 44.2% Annualized Using Options
News Imagea month ago - FibroGen, Inc.FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer

FG-3246 demonstrated efficacy in adenocarcinoma selected cohorts receiving biologically active doses of FG-3246 at ≥ 1.2 mg/kg in heavily pre-treated,...

News Imagea month ago - FibroGen, Inc.FibroGen to Present at 23rd Annual Needham Virtual Healthcare Conference

SAN FRANCISCO, March 26, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that Thane Wettig, Chief Executive Officer, will...

News Imagea month ago - InvestorPlace3 Nightmare Nasdaq Stocks Not Worth Holding Another Day

Selling these three NASDAQ stocks might be the best option now, as they continue to show potential issues and continued weakness.

News Image2 months ago - FibroGen, Inc.FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer

SAN FRANCISCO, March 11, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the appointment of Deyaa Adib, M.D., an executive leader...

News Image2 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news affecting shares on Tuesday morning!

News Image2 months ago - Seeking AlphaAstraZeneca returns right to roxadustat to FibroGen (NASDAQ:FGEN)

AstraZeneca returns rights to FibroGen for roxadustat, a drug used for treating anemia related to chronic kidney disease. Read more here.

News Image2 months ago - FibroGen, Inc.FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results

•  Topline data from two pivotal pamrevlumab pancreatic cancer trials anticipated in 2Q 2024 •  Additional data from Phase 1 monotherapy study of FG-3246...

News Image2 months ago - FibroGen, Inc.FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZeneca Territories, Except China and South Korea

The FibroGen – AstraZeneca China Agreement for Roxadustat remains in place FibroGen to explore licensing opportunities for Roxadustat SAN FRANCISCO,...

FGEN Links
Follow us for more